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ABSTRACT
The Impact of Mental Health Conditions on Public Insurance Costs of Treating
HIV/AIDS
The prevalence of mental illness among people living with HIV (PLWH) 
is high. Depressed PLWH are more likely to engage in high risk sexual 
behaviors that increase the chance of transmitting the HIV virus. PLWH with 
untreated mental health conditions experience negative health outcomes, 
including death, due to lower rates of initiating and adhering to anti-
retroviral therapy. They also use emergency departments more frequently 
and incur higher costs. 
This paper analyzes Medicare and Medicaid insurance claims 
data for Californians living with HIV in order to determine: 1)The 
prevalence of treatment for particular mental health diagnoses among 
PLWH with Medicare or Medicaid insurance in 2010; 2)The relationship 
between individual mental health conditions and total medical care 
expenditures; 3)The impact of individual mental health diagnoses on 
the cost of treating non-mental health conditions; and 4)The 
implications of the cost of mental health diagnoses for setting 
managed care capitation payments.
Keywords: HIV/AIDS; mental health; treatment costs; Medicare; 
Medicaid managed care capitations
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INTRODUCTION
The prevalence of mental illness among people living with HIV 
(PLWH) is high.(1-7).  Substantial percentages of PLWH have mood 
disorders.(1, 2, 5, 8) Rates of depression are three times as high 
among PLWH as among those who are seronegative.(4, 8, 9)  In a 
meta-analysis, the pooled prevalence of depression across nine studies
covering 7375 PLWH was 41%.(10) Even rates calculated over short 
time periods are substantial.  The Medical Monitoring Project, a 
nationally representative sample of adults receiving care for HIV in the 
U.S., found that 25.6% had experienced depression in the prior two 
weeks, with 12.4% of the sample experiencing major depression.(4, 8) 
Similarly, Bengtson et al found that 26% of HIV positive men and 29% 
of HIV positive women showed signs of depression.(11) In a diverse 
group of HIV-positive patients engaged in routine care, 39-44% showed
signs of depression.(12) Similarly 28% of women with HIV and 19% of 
men with HIV were assessed with current depression.(13) Higher rates 
have been found in some subpopulations, especially HIV-positive 
minority men. In the mStudy, 65.2% of the primarily minority PLWH 
had a history of psychiatric illness and 56.8% were currently 
depressed.(5) Additionally, among HIV patients, 16.2% reported 
anxiety, a rate significantly higher than among HIV-negative patients 
(6.9%; p=.009).(7) 
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Depressed PLWH are more likely to engage in high risk sexual 
behaviors that increase the chance of transmitting the HIV virus.(14)  
PLWH who have untreated mental health conditions also experience 
negative health outcomes due to lower rates of initiating and adhering 
to anti-retroviral therapy (ART) (10, 15, 16), but there were few 
significant relationships between anxiety disorders and adherence to 
ART. (17) Current depression is also linked to increased use of 
emergency departments and higher costs. (18)  In a large urban 
treatment program in 2003 PLWH who were comorbid for Serious 
Mental Illness (SMI) had 85% greater Medicaid costs than persons with 
only HIV and twice the costs of persons with only a SMI diagnosis.(19)  
To better understand the added needs and public insurance 
treatment costs for PLWH who also have mental health issues, this 
study examines Medicaid and Medicare insurance claims data prior to 
the time when most PLWH covered by Medi-Cal (California’s Medicaid 
program) were moved into managed care. This paper provides a broad 
view of the impact of a number of mental health conditions on health 
care utilization by analyzing insurance claims data for Californians 
living with HIV who are covered by Medicare and Medicaid in order to 
determine:
1. The prevalence of treatment for particular mental health 
diagnoses among PLWH with Medicare and Medicaid insurance in 
California in 2010
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2. The relationship between individual mental health 
conditions and total medical care expenditures
3. The impact of individual mental health diagnoses on the 
cost of treating non-mental health conditions
4. The implications of the cost of mental health diagnoses for 
setting MCO capitations
METHODS
Data. 
Data for this analysis consist of Medicare and Medicaid insurance
claims for Californians in 2010 acquired through a confidential data use
agreement with the Centers for Medicare and Medicaid Services (CMS).
We applied a case-identification algorithm to create an analysis file of 
adult beneficiaries with verifiable HIV.(20) Our analyses were limited to
individuals enrolled for the full year in fee-for-service arrangements 
because available data for Medicare and Medicaid managed care 
enrollees lack diagnosis fields needed to confirm HIV status. Data 
acquisition was reviewed and approved by the CMS Privacy Board. 
Research was also approved for expedited review by the relevant 
Institutional Review Board (IRB #10-000823).  Data were obtained in 
research identifiable files; storage, analysis, and reporting met CMS 
data security requirements. 
Individual characteristics.  
Insurance. Medicare reimbursement rates generally exceed 
those in Medicaid, therefore we distinguish two types of public 
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insurance: The Medicare group includes aged and long-term disabled 
beneficiaries with HIV for whom Medicare is the primary payer.  This 
group includes Dual eligibles who have Medicaid as a secondary payer.
The Medicaid-Only group has Medicaid coverage, but no Medicare 
coverage. 
Mental health. Mental health disorders were classified using the 
Clinical Classifications Software (CCS) from the Health Care Utilization 
Project.(21) Diagnoses were identified by relevant ICD-9 diagnosis 
codes appearing in an individual’s inpatient medical claims at least 
once or at least twice in outpatient claims on different days. We 
grouped the CCS mental health diagnoses into 4 major categories: 
mood disorders, adjustment and anxiety disorders (combining two CCS
diagnostic groups), schizophrenia and other psychoses, and all other 
mental health disorders (attention-deficit, conduct, and disruptive 
behavior disorders; delirium, dementia, amnestic, and other cognitive 
disorders; developmental disorders; disorders usually diagnosed in 
infancy, childhood, or adolescence; impulse control disorders; 
personality disorders; screening and history of mental health disorders;
and miscellaneous mental health disorders). None of the diagnoses 
combined into the ‘other’ category had a prevalence rate greater than 
1.5%. Information on alcohol and substance use disorders and 
suicidality were redacted by CMS. Patients could have more than one 
mental health diagnosis. 
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Comorbidities. The Charlson Comorbidity Index (CCI) is a 
validated method of classifying comorbidity documented in medical 
records to predict long- and short-term mortality.(22)  We identified 16 
comorbidities that are part of the Charlson scale (requiring a single 
inpatient claim or multiple outpatient claims on different days with 
relevant ICD-9 codes): myocardial infarction, congestive heart failure, 
peripheral vascular disease, cerebrovascular disease, dementia, 
chronic pulmonary disease rheumatic disease, peptic ulcer disease, 
mild liver disease, diabetes with chronic complications, diabetes 
without chronic complications, hemiplegia or paraplegia, renal disease,
any malignancy, moderate or severe liver disease, or metastatic solid 
tumor. AIDS-defining conditions and substance use were not included 
as comorbidities. We classified individuals as having zero, one, or two 
or more Charlson comorbidities.
Other. CMS enrollment data provided information on participant 
age, race, and gender. 
Outcome variables. 
 Medical care expenditures were extracted from inpatient, 
outpatient, prescription drug, and long term care files (the latter 
limited to Medicaid-Only and dual Medicare-Medicaid enrollees). 
Expenditures included all costs reimbursed by Medicare and Medicaid 
plus costs paid by the patient (e.g. deductible and coinsurance).   We 
disaggregated inpatient and outpatient expenditures into two 
categories: mental health expenditures were calculated by summing 
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over claims that had a mental health diagnosis in the first diagnosis 
field; non-mental health expenditures came from claims with other 
diagnosis codes in the first field.  We also calculated spending on 
antiretroviral (ARV) drugs, spending on other pharmaceuticals, and 
Medicaid expenditures for long term care.  Drug and long term care 
expenditures were not broken out by whether they were for mental 
health. 
Statistical analysis.
 All analyses were performed separately for Medicare and 
Medicaid-Only enrollees. Prevalence rates of mental health disorders 
were examined overall, and by individual characteristics. We 
calculated mean outpatient expenditures, prevalence of inpatient 
stays, mean inpatient expenditures conditional on having an inpatient 
stay, mean expenditures on antiretroviral medications and other 
prescription medications, and on long term care – overall and by 
mental health diagnosis.  Outpatient and inpatient spending was also 
broken out by whether it related to mental health or non-mental health
care.  T-tests compared differences in mean spending for enrollees 
with and without any mental health diagnoses.
To control for multiple influences on health spending, we 
estimated multivariable regressions that related medical care spending
to demographics, type of insurance, mental health diagnoses and other
comorbidities.  Outpatient spending was examined in one step since all
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the members of the analysis file had outpatient utilization. The cost of 
inpatient use was estimated in two steps: a logistic regression 
examined the factors related to hospitalization; a multivariable 
regression then examined inpatient expenditures conditional on any 
hospital use. Due to the skewness of the data, we transformed each 
individual’s outpatient and conditional inpatient expenditure with a 
natural logarithm. We present estimated percentage changes and odds
ratios showing the impact of the mental health variables in each 
regression, controlling for demographic and health variables. Full 
results from each model are provided in an appendix.
RESULTS
Mental health diagnoses were frequent in our analysis file of 
17,000 Californians with HIV enrolled in Medicare and Medicaid. About 
¼ of enrollees were treated for a mental health diagnosis in 2010 
(23.0% of those with any Medicare coverage and 28.1% of Medicaid-
only enrollees (Table 1).  The most prevalent diagnosis was mood 
disorders (16-18%).  However, adjustment/anxiety disorders (5.6-6.2%)
were not uncommon and there was a high prevalence of psychoses, 
including schizophrenia, particularly among the PLWH with only 
Medicaid insurance (8.1%).  Four percent of persons with Medicare had
received a diagnosis of psychosis.  Nearly one quarter (23.1%) of the 
group had at least one of these three diagnoses, with 3.1-4.8% having 
any of the other mental health diagnoses.
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Female Medicare recipients were more likely to have a mental 
health diagnosis (26.2%) than male Medicare recipients (22.6%) 
(p=.005) (Table 1). Among Medicaid-Only recipients, women were also 
more likely than men to be diagnosed with a mental health condition 
(30.2% of women vs. 27.3% of men) (p=.02). Women with Medicaid-
Only were as likely as men (8.1%) to be diagnosed with a psychosis. 
Prevalence of mental health conditions differed by race/ethnicity in 
both the Medicare (p<.001) and Medicaid-Only (p=.025) groups, with 
Whites more likely than either African Americans or Hispanics to have 
a mental health diagnosis. Mental health diagnoses differed by age 
among Medicare recipients (p<.001), with a lower rate among those 
over 65 (14.6%) than among younger enrollees (23.8-26.0%).  People 
with more comorbidities had significantly greater rates of mental 
health diagnosis in both the Medicare and Medicaid-Only group 
(p<.001). The prevalence of mental health disorders was significantly 
higher among the Medicare population with Dual coverage (25.5%), 
compared to those with Medicare only (17.9%) (p<.001).
Table 2 shows that mean health care expenditures for PLWH who
have a mental health diagnosis are significantly higher than for those 
with no mental health diagnosis ($62,650, vs. $42,319 in Medicare and
$49,788 vs. $34,934  in Medicaid; p<.001).  Costs of mental health 
care contributed to this differential, averaging $4,523 for Medicare 
recipients and $4,787 for Medicaid-Only recipients with mental health 
diagnoses (15.2% of Medicare outpatient and inpatient expenses and 
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23.5% of comparable Medicaid expenses).  Mental health costs are 
particularly high among patients with psychoses both in Medicare 
($18,943) and Medicaid-Only ($10,213). Half of patients with psychosis
in Medicare (53.6%) and nearly half of all Medicaid-Only enrollees with 
a mental health condition other than depression (48.3%) were 
hospitalized in 2010.
 However, the greater treatment costs for mental health 
conditions do not fully account for the greater medical spending of 
PLWH with a mental health diagnosis compared to those without such 
a diagnosis. Table 2 shows that health care expenditures were higher 
in every category, including for non-MH conditions, for people with 
mental health diagnoses than for those without, with the exception of 
expenditures for ARVs and conditional inpatient Medicaid spending, 
where the two groups were very similar.
To estimate the net relationship between medical expenditures 
and mental health diagnoses, we estimated multivariable regressions 
that control for the differences in demographics and in comorbidities 
shown in Table 1 between persons with a mental health condition and 
those without such a diagnosis.  
 The regressions allow us to isolate the effect of each particular 
mental health condition on health expenditures, since the conditions 
were not defined to be mutually exclusive. Table 3 presents the 
estimated percentage increase in spending for total inpatient and 
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outpatient care and for non-mental health inpatient and outpatient 
spending that is related to each mental health condition. Each of the 
mental health diagnoses was positively related to total outpatient 
costs, even after controlling for demographics, comorbidities, and 
other mental health conditions. On net, mood disorders were 
associated with more than 50% greater total costs for outpatient 
health care (52.9% in Medicare; 52.8% in Medicaid-Only). Medicare 
enrollees with an adjustment/anxiety diagnosis had 38.8% greater 
outpatient costs than Medicare enrollees without that diagnosis; 
Medicare enrollees with psychoses had 32.6% greater costs; and 
persons with other mental health diagnoses had 23% greater costs 
compared to PLWH who did not have these diagnoses.  For Medicaid-
Only enrollees, each mental health diagnosis type was associated with 
more than 50% greater outpatient spending than PLWH without that 
mental health diagnosis (52.8% for mood disorders; 50.5% for 
Adjustment/Anxiety; 57.8% for Psychoses; 62.4% for other mental 
health diagnoses (Table 3). Hospitalization rates were also significantly
higher (except in the case of Medicare enrollees with 
adjustment/anxiety disorders) for beneficiaries with a mental health 
diagnosis.
The cost of mental health treatment contributed to the higher 
total outpatient costs and greater use of inpatient services. 
Furthermore, PLWH who had mental health conditions also spent more 
on services that were not related to mental health. Spending on non-
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mental health outpatient care was 38.5% higher for Medicare enrollees
with mood disorders, and 22.4% higher for Medicaid.  Persons with 
adjustment/anxiety disorder spent approximately 30% more on 
outpatient medical care for non-mental health issues (31.5% more in 
Medicare; 29.6% more in Medicaid) (Table 3).  Medicare recipients with
psychoses spent 15.8% more on non-mental health outpatient care, 
but there was no significant increase among Medicaid-Only recipients 
with psychoses. PLWH with mental health diagnoses for the most part 
had greater odds of being hospitalized for a non-mental health 
condition (except for Medicare enrollees with adjustment/anxiety and 
Medicaid-Only enrollees with psychoses).  However, once hospitalized, 
patients with mood disorders, adjustment/anxiety disorder or 
psychoses did not have greater inpatient spending than other 
inpatients without a mental health diagnoses.
DISCUSSION
This study of publicly insured Californians with HIV documented 
high levels of treatment for mental health conditions, particularly 
depression. We find that about 1/6 of people in treatment for HIV 
received a diagnosis of depression (16.2% of Medicare and 17.8% of 
Medicaid recipients.) These estimates, based on claims data, are 
comparable to those based on medical record and survey data.  For 
example, 21.7% of a sample of PLWH receiving care in North Carolina 
and 25% of PLWH receiving care in Alabama were found to be 
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depressed based on self-reports on the Patient Health Questionnaire 
(PHQ). (13, 23)  A study of HIV patients in London also fielded the PHQ 
and found that 19.8% of the patients were depressed.(7)  Twenty-two 
percent of the nationally representative MMP sample reported 
depressive symptoms on the PHQ in a two-week period.(24) 
 Anxiety/adjustment disorders are also prevalent among 
Medicare (5.6%) and Medicaid (6.2%) enrollees. These analyses found 
high prevalence of psychoses among Medicare enrollees (4.0%), and 
twice that rate among Medicaid enrollees (8.1%).  These findings 
extend the existing literature, which focuses on mood disorders and 
relies on smaller clinical samples for other mental health conditions.
(25). 
 Medicare health care costs for PLWH who had a mental health 
diagnosis averaged $62,600 per year in 2010, compared to $42,300 for
PLWH without a mental health diagnosis. Among the Medicaid-Only 
group the cost differential was $49,800 vs. $34,900. The effect sizes 
varied across diagnoses. Individuals with psychoses averaged annual 
costs of $82,900, which was primarily attributable to greater inpatient 
costs driven by high rates of hospitalization (53.6% in Medicare and 
48.1% in Medicaid). Our multivariable analyses, which control for 
patient demographics and comorbidities, show that Medicare enrollees 
with a mental health diagnosis spent 23% to 53% more on outpatient 
care than those without a mental health diagnosis.  Medicaid enrollees 
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had more than 50% greater outpatient costs than PLWH without a 
mental health diagnosis.   Mental health conditions also had a dramatic
effect on the odds of being hospitalized.   
Our approach is innovative in examining not only the cost of 
mental health treatment, but also the impact of mental health 
conditions on non-mental health spending. On average, treatment 
costs for mental health conditions accounted for 15.2% of total annual 
inpatient and outpatient costs.   
Not only did PLWH who had a mental health diagnosis incur costs
to receive mental health care of $4000 to $5000 per year, but they 
also had greater costs for non-mental health care.  In particular, 
individuals with both mood disorders and adjustment/anxiety disorders
had elevated expenditures on non-mental health care in the outpatient
sector. 
Untreated mental health conditions negatively impact HIV 
outcomes. A meta-analysis found that PLWH with depression were 
significantly more likely to not use ART(10). However, we found that 
use of ARVs did not differ significantly between the Medicare and 
Medicaid enrollees with and without a mental health diagnosis.     
Depressed patients in the mSTUDY had lower rates of adherence to 
ART and were less likely to be virally suppressed.(5) In a sample of 
community-recruited impoverished PLWH who used ART, those who 
screened positive for severe mental illness had viral loads that were six
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times greater than for the group that did not show signs of severe 
mental illness.(26)  A meta-analysis showed that poor mental health 
relates not only to greater levels of viral load and lower CD4 counts, 
but also to an increased risk of death. (27) (28) 
Mental health treatment can ameliorate these effects by 
improving retention in care. (23) Among ART users, mental health 
treatment has been shown to increase adherence to ART (26, 29) HIV 
patients visiting clinics that provided psychiatric, psychologic and 
social services as well as treatment for Hepatitis are more than 3 times
as likely to achieve viral suppression as patients receiving treatment in
clinics that offered only HIV primary care.(30) 
Given the deleterious effects of untreated mental health 
conditions on viral load, mortality, and HIV transmissions, it is vital that
public insurance programs provide adequate access to mental health 
treatment for PLWH. In addition to the advantages for the PLWH, the 
community benefits because PLWH who are virally suppressed are less
likely to transmit the virus. 
The US National HIV/AIDS Strategy emphasizes the need for 
interdisciplinary HIV care that incorporates behavioral health 
treatment, such as that provided by Ryan White providers. Since its 
inception, the Ryan White program has emphasized the need for 
interdisciplinary HIV care that incorporates behavioral health 
treatment. An unintended consequence of the Affordable Care Act’s 
16
Medicaid Expansion was that this comprehensive care package, 
including treatment for behavioral issues in addition to medical 
treatment, became less available to many low-income PLWH who had 
been receiving care at Ryan White sites prior to 2014. Many Ryan 
White patients were required to enroll in Medicaid since Ryan White is 
designed to serve the uninsured and underinsured. Most of the new 
Medicaid eligibles in California had to enroll in managed care 
organizations (MCOs), which are compensated with a fixed monthly 
capitation to provide all necessary  treatment. 
Setting MCO capitation rates that reflect expected treatment 
costs is essential to insuring access to both physical and mental health
treatment for PLWH.  The movement of most California Medicaid 
enrollees with HIV into MCOs increases the urgency of understanding 
how mental health conditions affect the need for services—both 
treatment for mental health conditions and non-mental health 
conditions. Although MCOs currently receive an enhanced capitation 
for both Dual eligibles and Medicaid-Only enrollees with AIDS, there is 
not an enhanced rate for HIV alone. ART costs are carved out of most 
Medicaid MCO capitation rates in California, thereby preserving access 
to critical antiretroviral therapy. Since 2014, services for more severe 
mental health problems have also been carved out of Medi-Cal 
managed care contracts, and are provided by the counties,(31, 32).  
However, this paper shows that simply carving out treatment for 
severe mental illness from the costs that managed care organizations 
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are required to pay does not adequately compensate the MCOs for the 
added costs of PLWH who have mental health diagnoses, including for 
hospitalization and for treatment for conditions other than mental 
health.
Limitations:  The analysis uses data that relate to a single period 
in time (2010), thus it is not possible to determine causality.  It is 
possible that being hospitalized led to depression rather than 
depression leading to hospitalization.  However, the finding that most 
mental health conditions were also associated with more frequent 
outpatient and inpatient use for non-mental health conditions, provides
support for the causal effect running from mental health conditions to 
utilization rather than vice versa.  We chose to use data for 2010, a 
period when most of the Medicaid enrollees were treated in the fee-for-
service system because it allows us to examine utilization for severe 
mental health conditions, which is not possible with more recent 
periods in which California counties assume responsibility for these 
costs.
Second, since claims were used to identify having a mental 
health condition, some PLWH with a mental health condition for which 
they did not receive care may not have been identified.  In that case, 
the prevalence of mental health conditions would have been even 
greater than estimated here.  Per capita costs of mental health care 
may consequently have been overestimated because some PLWH were
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not treated for their mental health condition.  The effect of this 
omission on non-mental health spending cannot be predicted.  
Finally, levels of Medicaid expenditures for PLWH may not be 
directly generalizable to all states because California has relatively low 
levels of Medicaid reimbursement, averaging only 66% of the national 
mean reimbursement for primary care services..(33) As a result of the 
low reimbursement rates, Medicaid recipients in California may have 
had difficulty accessing mental health services through their providers 
and sought mental health care from Ryan White sites.  If this were the 
case, actual mental health need would be even greater than 
documented here. However, the finding that mental health conditions 
increased use all medical care and care for non-mental health issues in
both Medi-Cal and in Medicare suggests that the additional use of 
would apply to other states. The absolute levels of added expenditure 
would vary with state reimbursement levels.  Within a state, 
reimbursement levels are similar for patients with and without mental 
health conditions, so the percentage increase in use are likely to be 
more generalizable.
Conclusion: The prevalence of mental health conditions among 
PLWH covered by Medicare and Medicaid is high.  The greater 
expenditures for those with mental health conditions are not only 
attributable to their use of mental health services, but also to higher 
treatment costs for non-mental health conditions.  In order to preserve 
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access to both mental health and physical health services it is 
important to account for this additional non-mental health use when 
setting capitations for PLWH within managed care systems.
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